EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker

Khaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, Steven Kuan-Hua Huang, Yu-Feng Tian, Chia-Lin Chou, Yow-Ling Shiue iD, Keva Joseph, I-Wei Chang iD

Diagnostics · 06.07.2023 · 13 (13) · 2296

DOI: 10.3390/diagnostics13132296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 06.07.2023. Verfasst von Khaa Hoo Ong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology & General Surgery, Department of Surgery, Chi Mei Medical Center, Tainan 710, Taiwan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic cholangiocarcinoma (IHCC) is the second most common malignant neoplasm of the liver. In spite of the increasing incidence worldwide, it is relatively rare in Western countries. IHCC is relatively common in Eastern and Southeastern Asia. Patients with IHCC are usually diagnosed at an advanced stage, therefore, the clinical outcome is dismal. Dysregulation of urea cycle metabolic enzyme expression is found in different types of cancers. Nevertheless, a comprehensive evaluation of genes related to the urea cycle (i.e., GO:0000050) has not been conducted in IHCC. By performing a comparative analysis of gene expression profiles, we specifically examined genes associated with the urea cycle (GO:0000050) in a publicly accessible transcriptomic dataset (GSE26566). Interestingly, CPS1 was identified as the second most prominently down-regulated gene in this context. Tumor tissues of 182 IHCC patients who underwent curative-intent hepatectomy were enrolled. The expression level of CPS1 protein in our IHCC cohort was assessed by immunohistochemical study. Subsequent to that, statistical analyses were carried out to examine the expression of CPS1 in relation to various clinicopathological factors, as well as to assess its impact on survival outcomes. We noticed that lower immunoreactivity of CPS1 in IHCC was associated with tumor progression (pT status) with statistical significance (p = 0.003). CPS1 underexpression was not only negatively correlated to overall survival (OS), disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) in univariate analysis but also an independent prognosticator to forecast poorer clinical outcome for all prognostic indices (OS, DSS, LRFS and MeFs) in patients with IHCC (all p ≤ 0.001). These results support that CPS1 may play a crucial role in IHCC oncogenesis and tumor progression and serve as a novel prognostic factor and a potential diagnostic and theranostic biomarker.

Schlagwörter

Stichwörter der Autor:innen

CPS1biomarkercarbamoyl phosphate synthetase Idiagnosticintrahepatic cholangiocarcinomaprognosistheranosticurea cycle

Autor:innen und Institutionen

  • Division of Gastroenterology & General Surgery, Department of Surgery, Chi Mei Medical Center, Tainan 710, Taiwan.
  • Department of Medical Technology, Chung Hwa University of Medical Technology, Tainan 717, Taiwan.
  • Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 804, Taiwan.
  • Division of Hematology and Oncology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei 235, Taiwan.
  • Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • Division of Urology, Department of Surgery, Chi Mei Medical Center, Tainan 710, Taiwan.

ORCID-Profile: Yow-Ling Shiue, I-Wei Chang

Zitieren

APA

Ong, K. H., Hsieh, Y. Y., Sun, D. P., Huang, S. K., Tian, Y. F., Chou, C. L., Shiue, Y. L., Joseph, K., & Chang, I. W. (2023). Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. Diagnostics, 13(13), 2296. https://doi.org/10.3390/diagnostics13132296

Vancouver

Ong KH, Hsieh YY, Sun DP, Huang SK, Tian YF, Chou CL, et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. Diagnostics. 2023;13(13):2296. doi:10.3390/diagnostics13132296

BibTeX
@article{Ong2023,
  author = {Ong, Khaa Hoo and Hsieh, Yao-Yu and Sun, Ding-Ping and Huang, Steven Kuan-Hua and Tian, Yu-Feng and Chou, Chia-Lin and Shiue, Yow-Ling and Joseph, Keva and Chang, I-Wei},
  title = {Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {13},
  pages = {2296},
  doi = {10.3390/diagnostics13132296}
}
Kostenlos starten →